Jordana Jampel

Jordana Jampel, MA

Articles by Jordana Jampel

Jordana JampelMetabolic Disorders | April 17, 2025
The guideline supports "value- and preference-sensitive decision-making" for children with obesity and their families.
Read More
Jordana JampelPulmonology | April 15, 2025
Primary outcomes included new diagnosis of diabetes, cataracts, pneumonia, osteoporosis, or nontraumatic fractures.
Jordana JampelGastroenterology | April 17, 2025
Premature death was defined as death before age 75 years, which was the primary study outcome.
Jordana JampelPreventive Cardiology | April 17, 2025
The newly approve products include four new sizes.
Jordana JampelNeurology | April 8, 2025
ALS Functional Rating Scale-Revised results scores were used to determined therapeutic efficacy versus placebo.
Jordana JampelCardiology | April 7, 2025
PEGS were developed from whole-blood DNA methylation samples for items such as blood pressure, BMI, and C-reactive protein.
Jordana JampelDermatology | April 2, 2025
Relative rates of serious infection were calculated using medication use time versus time not used.
Jordana JampelHead and Neck Cancer | March 28, 2025
AI analysis provides an opportunity for timely intervention to improve the ability to swallow as well as quality of life.
Jordana JampelNeurodivergent | March 26, 2025
Somatic comorbidities that were considered included allergies, asthma, skin diseases, and migraine, to name a few.
Jordana JampelHead and Neck Cancer | March 26, 2025
Euphorbis tirucalli leaf extract has the potential ability to inhibit EBV-positive cell proliferation.
Jordana JampelCervical Cancer | March 20, 2025
Researchers assessed ICD gene expressions to predict immunotherapy response and immune cell infiltration.
Jordana JampelGastroenterology | March 17, 2025
At baseline and after 2 months, patients underwent clinical assessments, WHOQOL-BREF evaluation, and 24-hour dietary recalls.
Jordana JampelTriple-Negative Breast Cancer | March 25, 2025
Researchers aimed to evaluate the roll of ERCC1 expression in predicting response to adjuvant chemotherapy for TNBC.
Jordana JampelHER2 Breast Cancer | March 25, 2025
TILs can serve as a biomarker to identify patients with ERBB2-positive early breast cancer who can reduce adjuvant therapy.
Jordana JampelHead and Neck Cancer | February 21, 2025
Researchers identified 23,450 trial sites; a majority of them began before 2020.
Jordana JampelMelanoma | February 21, 2025
The main features of intestinal inflammation are reproduced as a biomarker for response to immune checkpoint inhibition.
Jordana JampelBreast Cancer News | March 25, 2025
There was a 29% increase in cancer detection with AI-supported screening.
Jordana JampelDiabetes | February 20, 2025
The two predictive models are called the Diabetes Remission Index and the Weight Loss-Adjusted Diabetes Remission Index.
Jordana JampelGastroenterology | February 14, 2025
The primary study outcome was the development of endoscopic inflammatory pouch disease.
Jordana JampelHIV | February 14, 2025
The model takes into consideration that different social factors present different types of access barriers.